Table 4.
Univariate analysis
| Variable | n | ncensored | % | P-value |
|---|---|---|---|---|
| Age (years) | 0.115 | |||
| < 65 | 9 | 3 | 33.3 | |
| ≥65 | 62 | 11 | 17.7 | |
| Co-morbidities | 0.971 | |||
| Yes | 58 | 13 | 22.4 | |
| No | 13 | 1 | 7.6 | |
| Total | 71 | 14 | ||
| Lesions | ||||
| Tumor size (mm) | 0.782 | |||
| ≤20 | 26 | 7 | 26.9 | |
| > 20 | 75 | 19 | 25.3 | |
| Histology | 0.093 | |||
| SCC | 31 | 15 | 48.4 | |
| BCC | 70 | 11 | 15.8 | |
| Fraction (Gy) | < 0.001 | |||
| ≤3 | 44 | 18 | 40.9 | |
| > 3 | 57 | 8 | 14.0 | |
| EQD2 | < 0.001 | |||
| ≤50 | 48 | 18 | 37.5 | |
| > 50 | 53 | 8 | 15.1 | |
| Total | 101 | 26 | ||
SCC – squamous cell carcinoma, BCC – basal cell carcinoma, EQD2 – dose equivalent to 2 Gy